spacer
home > pmps
PUBLICATIONS

Pharmaceutical Manufacturing and Packing Sourcer

 

Pharmaceutical Manufacturing and Packing Sourcer (PMPS) is a specialist journal designed to provide worldwide coverage of a range of topics relating to the pharmaceutical manufacturing and packaging sector.

Published quarterly, the journal functions as a platform of communication and information-sharing for executive and strategic decision-makers within the industry, identifying new trends and marketing opportunities as well as highlighting the latest innovations in this dynamic environment. PMPS is specifically designed to interest those in the pharmaceutical, biotech, nutritional and medical device industries who are actively seeking to source services for improved efficiency in what is an increasingly competitive market.




 
For further information please contact:

Advertising
Nicholas Matthews

Editorial
Amy McKavanagh

We're also on Twitter! Follow us @PMPSmag  

Read our publications on the go in the Samedan app for iPhone and iPad. You can download issues for offline reading and our archives go as far back as 2008! Download for free on the App Store.


Click here to view the digital version of PMPS

 


  Click here to view the digital version of Parenteral Technology
 

pmps
 
 
Featured in this issue
Highly Potent Products
The REACH Regulation

Supervising Substances


Meeting REACH’s standards has been a considerable hurdle for companies. While aiming to protect people from hazardous chemicals, its extensive rules and regulations complicate procedures, claims Farmak’s Jana Osičková.
RFID & ANTI-COUNTERFEITING
RFID Labelling for Trials

High Demands


Faubel’s Anthony Morrow highlights the benefits of radio-frequency identification technology implementation within labelling to create stronger clinical trial supply chains.
  PACKING & PACKAGING
The Potential of Packaging

More than Boxes and Bottles
 
Patient nonadherence can be linked to poor packaging. Oliver Pittock at Valley Northern investigates the current state of compliance and how it can be guaranteed through industry standards.

spacer
Edited by
Randice Altschul
Chief Executive Officer at Pop Test and Palisades Therapeutics

Published quarterly in
February, May,
August and November

Banner of Singapore Airlines on Samedan
 
Widgets Magazine

Industry Events

5th Biennial Biosimilars & Biobetters Congress 2018

16-17 April 2018, Novotel London West Hotel, Hammersmith, London

Oxford Global are proud to present our highly anticipated 5thBiennial Biosimilars & Biobetters Congress, 16th – 17thApril 2018, London, UK. Over 450 proteins, peptides and biosimilars delegates representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions will enjoy over 20 presentations and case studies focusing on the key areas of the biosimilars industry including market access strategies, clinical development, commercialisation, manufacturing and bio-analytics
More info >>

 
News and Press Releases

Synpromics expands facilities to meet demand for revolutionary gene control technology

Edinburgh, UK, 11th September 2017 - Synpromics Ltd, the leader in gene control and synthetic promoter development, today moves to new world-class facilities at the Roslin Innovation Centre. Synpromics is expanding to meet increasing global demand for its cutting-edge gene control technology, and is the first company to move into the new custom-built centre based at the University of Edinburgh’s Easter Bush Campus.
More info >>

air transport logo

 

White Papers

Life Cycle of an Analytical Method - a Case Study on the Monocyte Activation Test

Wickham Laboratories Limited

Pyrogens, a heterogeneous group of fever inducing contaminants, are comprised of microbial and non-microbial compounds; e.g. endotoxin (lipopolysaccharide, LPS) produced by Gram-negative bacteria, lipoteichoic acid (LTA) from Gram-positive bacteria, bacterial DNA (CpG-motive), endogenous pyrogens, virus and fungi particles or even fragments of packaging materials, plastic and dust. Contaminat ion wi th pyrogens in pharmaceutical products, biotherapeutics and on medical devices can lead to life threatening fever reactions. To ensure consumer safety, pyrogen testing is mandatory for parenteral products and medical devices.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement